Product information and disease descriptionProduct descriptionProduct information
Dosage forms and strengths
4 evidence topics · 5 sources
Dose administered in the RINGSIDE phase 3 trial
Capsule formulations in clinical pharmacology studies
Capsule strengths of BMS-986115 in the Bristol-Myers Squibb phase 1 trial
Commercial dosage form and unit strengths
No evidence found.